Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001213900-24-101675
Filing Date
2024-11-22
Accepted
2024-11-22 17:08:33
Documents
16
Period of Report
2024-11-01
Items
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 TO FORM 8-K ea0222014-8ka1_lomond.htm   iXBRL 8-K/A 31002
2 UNAUDITED FINANCIAL STATEMENTS OF LOMOND OPERATING CO. AS OF AND FOR THE NINE MO ea022201401ex99-5_lomond.htm EX-99.5 245600
3 MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERA ea022201401ex99-6_lomond.htm EX-99.6 126207
4 UNAUDITED PRO FORMA COMBINED FINANCIAL INFORMATION OF LOMOND THERAPEUTICS HOLDIN ea022201401ex99-7_lomond.htm EX-99.7 108916
  Complete submission text file 0001213900-24-101675.txt   757398

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE cik0001900520-20241101.xsd EX-101.SCH 3090
6 XBRL LABEL FILE cik0001900520-20241101_lab.xml EX-101.LAB 34240
7 XBRL PRESENTATION FILE cik0001900520-20241101_pre.xml EX-101.PRE 22400
18 EXTRACTED XBRL INSTANCE DOCUMENT ea0222014-8ka1_lomond_htm.xml XML 4461
Mailing Address C/O LOMOND THERAPEUTICS HOLDINGS, INC. 8 THE GREEN STE 8490 DOVER DE 19901
Business Address C/O LOMOND THERAPEUTICS HOLDINGS, INC. 8 THE GREEN STE 8490 DOVER DE 19901 561 464 2841
Lomond Therapeutics Holdings, Inc. (Filer) CIK: 0001900520 (see all company filings)

EIN.: 872959575 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 000-56377 | Film No.: 241490822
SIC: 6770 Blank Checks
(CF Office: 05 Real Estate & Construction)